The subsequent phase 3 trial of tirzepatide demonstrated more effective reductions in the glycated hemoglobin levels and body weight, along with greater overall improvements in the lipid profile compared to semaglutide in patients with T2DM, elevating incretin therapeutic agents to a new level (112)
The GIP receptor is highly expressed in adipose tissue, and acute infusion of GIP under conditions of high insulin and modest hyperglycemia increases adipose tissue glucose uptake, blood flow, and triglyceride hydrolysis in humans [20, 21, 22]
Keep exploring in the PlexusDx Education Hub
Skipping steps or increasing the dose too quickly can lead to more severe side effects and compromise tolerability
Clinical Evidence Comparing Semaglutide And Tirzepatide Peer-reviewed research provides important context
Custom Shade, Fast Results These tan drops are easy to dose to your preferred glow level